Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glycodepot is a specialized marketplace and service provider dedicated to the glycoscience and glycomics sectors. Founded by Dr. Shukkoor M. Kondengaden, the company provides a centralized platform for researchers to access high-quality reagents, enzymes, and custom synthesis services. Its offerings include sugar nucleotides, glycosyltransferases, and glycan standards, as well as specialized services such as custom glycosylation, anti-glycan antibody development, and glycan characterization using GC-MS. Glycodepot aims to streamline the sourcing of complex carbohydrates and accelerate research in drug discovery, vaccine design, and biomarker identification. The company operates as a hub for the glycoscience community, connecting academic and industrial researchers with specialized tools and expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glycodepot.